{"title":"네이버 금융 ─ 뉴스 ─ 기업 종목분석","url":"https://finance.naver.com/news/news_list.naver?mode=LSS3D&section_id=101&section_id2=258&section_id3=402","favicon":"https://finance.naver.com/news/favicon.ico","elements":[{"title":"샐바시온, 국제 바이러스 학회 기조발표 … “코로나 예방제 코빅실-V에 전세계 이목 쏠렸다..","contents":"<a href=\"/news/news_read.naver?article_id=0004881483&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"샐바시온, 국제 바이러스 학회 기조발표 … “코로나 예방제 코빅실-V에 전세계 이목 쏠렸다”\">샐바시온, 국제 바이러스 학회 기조발표 … “코로나 예방제 코빅실-V에 전세계 이목 쏠렸다..</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004881483&office_id=009&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637288532366},{"title":"위메이드, 탈중앙화 금융 서비스 ‘클레바’ 연내 출시 예고","contents":"<a href=\"/news/news_read.naver?article_id=0004881482&amp;office_id=009&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"위메이드, 탈중앙화 금융 서비스 ‘클레바’ 연내 출시 예고\">위메이드, 탈중앙화 금융 서비스 ‘클레바’ 연내 출시 예고</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004881482&office_id=009&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637288532368},{"title":"버킷스튜디오·인바이오젠, ‘책임경영’ 강화한다","contents":"<a href=\"/news/news_read.naver?article_id=0004742453&amp;office_id=014&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"버킷스튜디오·인바이오젠, ‘책임경영’ 강화한다\">버킷스튜디오·인바이오젠, ‘책임경영’ 강화한다</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004742453&office_id=014&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637288532371},{"title":"JW중외제약, 신테카바이오와 혁신신약 개발 협약 체결","contents":"<a href=\"/news/news_read.naver?article_id=0004630573&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"JW중외제약, 신테카바이오와 혁신신약 개발 협약 체결\">JW중외제약, 신테카바이오와 혁신신약 개발 협약 체결</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004630573&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637288532372},{"title":"JW중외제약, 신테카바이오와 AI 활용 혁신신약 개발 MOU 체결","contents":"<a href=\"/news/news_read.naver?article_id=0004672743&amp;office_id=008&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"JW중외제약, 신테카바이오와 AI 활용 혁신신약 개발 MOU 체결\">JW중외제약, 신테카바이오와 AI 활용 혁신신약 개발 MOU 체결</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004672743&office_id=008&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637288532373},{"title":"비덴트, 유상증자로 400억 현금 추가확보…빗썸 지분 확대하나","contents":"<a href=\"/news/news_read.naver?article_id=0004630550&amp;office_id=015&amp;mode=LSS3D&amp;type=0&amp;section_id=101&amp;section_id2=258&amp;section_id3=402&amp;date=20211119&amp;page=1\" title=\"비덴트, 유상증자로 400억 현금 추가확보…빗썸 지분 확대하나\">비덴트, 유상증자로 400억 현금 추가확보…빗썸 지분 확대하나</a>","link":"https://finance.naver.com/news/news_read.naver?article_id=0004630550&office_id=015&mode=LSS3D&type=0&section_id=101&section_id2=258&section_id3=402&date=20211119&page=1","retrieved":1637286536972}]}